Primary neuroendocrine neoplasms (NENs) of the breast are characterized by neuroendocrine architectural and cytological features, which must be supported by immunohistochemistry positivity for neuroendocrine markers (such as Chromogranin and Synaptophysin) [1]. This evidence concerns the gene SYP and neuroendocrine neoplasm.